Share Email Print

Journal of Medical Imaging • Open Access

Evaluation environment for digital and analog pathology: a platform for validation studies
Author(s): Brandon D. Gallas; Marios A. Gavrielides; Catherine M. Conway; Adam Ivansky; Tyler C. Keay; Wei-Chung Cheng; Jason Hipp; Stephen M. Hewitt

Paper Abstract

We present a platform for designing and executing studies that compare pathologists interpreting histopathology of whole slide images (WSIs) on a computer display to pathologists interpreting glass slides on an optical microscope. eeDAP is an evaluation environment for digital and analog pathology. The key element in eeDAP is the registration of the WSI to the glass slide. Registration is accomplished through computer control of the microscope stage and a camera mounted on the microscope that acquires real-time images of the microscope field of view (FOV). Registration allows for the evaluation of the same regions of interest (ROIs) in both domains. This can reduce or eliminate disagreements that arise from pathologists interpreting different areas and focuses on the comparison of image quality. We reduced the pathologist interpretation area from an entire glass slide (10 to 30  mm2) to small ROIs (<50  μm2). We also made possible the evaluation of individual cells. We summarize eeDAP’s software and hardware and provide calculations and corresponding images of the microscope FOV and the ROIs extracted from the WSIs. The eeDAP software can be downloaded from the Google code website (project: eeDAP) as a MATLAB source or as a precompiled stand-alone license-free application.

Paper Details

Date Published: 12 November 2014
PDF: 9 pages
J. Med. Img. 1(3) 037501 doi: 10.1117/1.JMI.1.3.037501
Published in: Journal of Medical Imaging Volume 1, Issue 3
Show Author Affiliations
Brandon D. Gallas, U.S. Food and Drug Administration (United States)
Marios A. Gavrielides, U.S. Food and Drug Administration (United States)
Catherine M. Conway, National Institutes of Health (United States)
Adam Ivansky, U.S. Food and Drug Administration (United States)
Tyler C. Keay, U.S. Food and Drug Administration (United States)
Wei-Chung Cheng, U.S. Food and Drug Administration (United States)
Jason Hipp, National Cancer Institute (United States)
Stephen M. Hewitt, National Cancer Institute (United States)

© SPIE. Terms of Use
Back to Top